|
|
Volumn 27, Issue 2, 1998, Pages 453-463
|
|
Therapy for osteoporosis: Miscellaneous and experimental agents
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANABOLIC AGENT;
CONJUGATED ESTROGEN;
ECHISTATIN;
GONADORELIN AGONIST;
IPRIFLAVONE;
NANDROLONE DECANOATE;
NITRIC OXIDE;
NITRIC OXIDE DONOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARATHYROID HORMONE[1-34];
PLACEBO;
RECOMBINANT GROWTH HORMONE;
SOMATOMEDIN BINDING PROTEIN 3;
SOMATOMEDIN C;
STRONTIUM;
THIAZIDE DIURETIC AGENT;
TRACE ELEMENT;
BONE DENSITY;
BONE MASS;
BONE METABOLISM;
BONE MINERAL;
BONE REMODELING;
CLINICAL TRIAL;
HIP FRACTURE;
HUMAN;
NONHUMAN;
OSTEOLYSIS;
OSTEOPOROSIS;
POSTMENOPAUSE OSTEOPOROSIS;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
VERTEBRA FRACTURE;
|
|
EID: 0031832613
PISSN: 08898529
EISSN: None
Source Type: Journal
DOI: 10.1016/S0889-8529(05)70016-5 Document Type: Article |
|
Times cited : (9)
|
|
References (113)
|
